Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Catalysts
Filings
Track record
Movers
The Lead Compound
Home
›
Targets
› TLR 7/8
TLR 7/8
(2 companies · 2 programs)
Companies with an active program directed at TLR 7/8.
Eikon Therapeutics, Inc.
EIKN
EIK1001
— Non-Small Cell Lung Cancer
Phase 2
Evommune, Inc.
EVMN
EVO646
Preclinical